Document Detail

Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
MedLine Citation:
PMID:  23196819     Owner:  NLM     Status:  Publisher    
PURPOSE: Oxaliplatin-induced neuropathy is a dose-related side effect which occurs in almost 40 % of patients treated with oxaliplatin. Aim of the present study was to identify reliable clinical factors predicting its development and duration. METHODS: One hundred sixty-nine completely resected colorectal cancer patients treated with adjuvant Folfox IV regimen were retrospectively included. The following pre-treatment clinical parameters were collected: hypocalcaemia, hypomagnesaemia, hypoalbuminaemia, anaemia, diabetes, chronic renal failure (CRF), folate deficiency, vitamin B(12) deficiency, number of cycles received and habit to alcohol consumption. Incidence, grade (NCI-CTCAE v.3) and duration of neuropathy were recorded. RESULTS: Incidence of neuropathy was found to be higher in patients with pre-treatment anaemia (p = 0.001), hypoalbuminaemia (p = 0.01) and hypomagnesaemia (p = 0.001) as well in those with habit to alcohol consumption (p = 0.003). Neuropathy durations were conversely associated with age, being longer in younger patients (p = 0.03), and again with hypoalbuminaemia (p = 0.04) and hypomagnesaemia (p = 0.002). No correlation was found with gender, hypocalcaemia, diabetes and CRF. The correlation between vitamin B(12) and folate levels and the development of neurotoxicity were not analysed because of the high number of missing data in the population. CONCLUSIONS: Age, anaemia, hypoalbuminaemia, hypomagnesaemia and alcohol consumption are reliable and easily assessable clinical factors predicting incidence and length of oxaliplatin-induced neuropathy.
Bruno Vincenzi; Anna Maria Frezza; Gaia Schiavon; Chiara Spoto; Raffaele Addeo; Vincenzo Catalano; Francesco Graziano; Daniele Santini; Giuseppe Tonini
Related Documents :
23797699 - Early major worsening in ischemic stroke: predictors and outcome.
24529579 - Utilization of renal mass biopsy in patients with renal cell carcinoma.
24848429 - Prevalence and associated factors of reduced bone mineral density in patients with idio...
24244449 - Cytokines and signaling molecules predict clinical outcomes in sepsis.
24981869 - Prognostic value of atrial fibrillation inducibility following right atrial flutter abl...
23408569 - Prevalence and natural history of graves' orbitopathy in a large series of patients wit...
22071999 - Clotting factor deficiency in early trauma-associated coagulopathy.
9702389 - Unrecognized major bleeding following thrombolysis for acute myocardial infarction pres...
17851929 - Clinical characteristics and genotype-phenotype correlation of hearing loss patients wi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-30
Journal Detail:
Title:  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer     Volume:  -     ISSN:  1433-7339     ISO Abbreviation:  Support Care Cancer     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9302957     Medline TA:  Support Care Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Medical Oncology, Università Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Are n-3 fatty acids still cardioprotective?
Next Document:  Effectiveness of a training program in supervisors' ability to provide feedback on residents' commun...